News of Note—Heat-stable TB shot, measles outbreak and more


Here is some other vaccine news of note for the week:

> Scientists have started phase 1 testing of ID93, a freeze-dried, temperature-stable recombinant tuberculosis vaccine candidate developed at the Infectious Disease Research Institute. NIH release

> The number of confirmed cases of measles in western Washington has grown to 36, as health officials have declared a state of emergency and are urging immunization. NPR article

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> A new poll by South Nassau Communities Hospital showed that parents are aware of the HPV vaccine but that some have no plans—or are unsure—whether they’ll have their children immunized. Newsday article

Suggested Articles

An FDA panel gave Sanofi's Dengvaxia a mixed endorsement, voting down its use in people 17 and older.

Prosecutors in the Philippines have found probable cause to indict six Sanofi officials for its Dengvaxia rollout.

The FDA has issued guidance on continuous manufacturing and is allocating $58 million to move forward advanced manufacturing processes.